Canakinumab

(Synonyms: Ilaris; ACZ 885)
1 Cited Publications
고객리뷰

Based on 1 publication(s) in Google Scholar

Canakinumab (ACZ885) is a recombinant human anti-IL-1β monoclonal antibody. Canakinumab shows IC50 values of 43.6 and 40.8 pM for human and marmoset IL-1β, respectively. The mode of action of canakinumab is based on the neutralization of IL-1β signaling, resulting in suppression of inflammation related to disorders of autoimmune origin.

연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.

  • Purity: 98.84%
  • CAS No.: 914613-48-2
  • 분자량:145.5 kDa
  • 보관:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biological Activity
  • Chemical Information
  • 순도&문서
  • References
  • Help & FAQs

Publications Citing Use of MedChemExpress (MCE) Canakinumab

More
100 mg

견적 받기 해외재고보유

Please select quantity
Amount: USD 0.00